Invasive Bacterial Infections in Infants Younger Than 60 Days With Skin and Soft Tissue Infections.
Journal
Pediatric emergency care
ISSN: 1535-1815
Titre abrégé: Pediatr Emerg Care
Pays: United States
ID NLM: 8507560
Informations de publication
Date de publication:
01 Jun 2021
01 Jun 2021
Historique:
pubmed:
22
8
2018
medline:
19
8
2021
entrez:
22
8
2018
Statut:
ppublish
Résumé
The objective of this study was to describe the frequency of invasive bacterial infections (IBIs) in young infants with skin and soft tissue infections (SSTIs) and the impact of IBI evaluation on disposition, length of stay (LOS), and cost. This retrospective (2009-2014) cohort study used data from 35 children's hospitals in the Pediatric Health Information System. We included infants younger than 60 days who presented to an emergency department (ED) with SSTI. Invasive bacterial infection was defined as bacteremia/sepsis, bone/joint infection, or bacterial meningitis. Readmission and return ED visits within 30 days were evaluated to identify missed IBIs for infants. A total of 2734 infants were included (median age, 33 days; interquartile range [IQR], 21-44); 62% were hospitalized. Invasive bacterial infection was identified in 2%: bacteremia (1.8%), osteomyelitis (0.1%), and bacterial meningitis (0.1%). Hospitalization occurred in 78% of infants with blood cultures, 95% with cerebrospinal fluid cultures, and 23% without cultures. Median hospitalization LOS was 2 days (IQR, 1-3). Median cost was US $4943 for infants with cerebrospinal fluid cultures (IQR, US $3475-6780) compared with US $419 (IQR, US $215-1149) for infants without IBI evaluations (P < 0.001). Five infants (0.2%) returned to the ED within 30 days with new IBI diagnoses (4 bacteremia, 1 meningitis). Invasive bacterial infection occurs infrequently in infants younger than 60 days who present to children's hospital EDs with SSTI. Bacteremia is the most common IBI. More extensive evaluation for IBI is associated with increased rate of admission, LOS, and cost. Further studies are needed to evaluate the safety of a limited IBI evaluation in young infants with SSTI.
Identifiants
pubmed: 30130340
pii: 00006565-202106000-00016
doi: 10.1097/PEC.0000000000001584
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e301-e306Informations de copyright
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosures: The authors declare no conflict of interest.
Références
Lopez MA, Cruz AT, Kowalkowski MS, et al. Trends in resource utilization for hospitalized children with skin and soft tissue infections. Pediatrics . 2014;131:718–725.
Lautz TB, Raval MV, Barsness KA. Increasing national burden of hospitalizations for skin and soft tissue infections in children. J Pediatr Surg . 2011;46:1935–1941.
Frei CR, Makos BR, Daniels KR, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg . 2010;45:1967–1974.
Vidwan G, Geis GL. Evaluation, management, and outcome of focal bacterial infections (FBIs) in nontoxic infants under two months of age. J Hosp Med . 2010;5:76–82.
Kharazmi SA, Hirsh DA, Simon HK, et al. Management of afebrile neonates with skin and soft tissue infections in the pediatric emergency department. Pediatr Emerg Care . 2012;28:1013–1016.
Hester G, Hersh AL, Mundorff M, et al. Outcomes after skin and soft tissue infection in infants 90 days old or younger. Hosp Pediatr . 2015;5:580–585.
Lopez MA, Cruz AT, Kowalkowski MA, et al. Factors associated with high resource utilization in pediatric skin and soft tissue infection hospitalizations. Hosp Pediatr . 2013;3:718–725.
Williams DJ, Cooper WO, Kaltenbach LA, et al. Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections. Pediatrics . 2011;128:479–487.
Elliott DJ, Zaoutis TE, Troxel AB, et al. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant staphylococcus aureus . Pediatrics . 2009;123:e959–e966.
Feudtner C, Feinstein JA, Zhong W, et al. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr . 2014;8:199. doi: 10.1186/1471-2431-14-199.
doi: 10.1186/1471-2431-14-199
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis . 2014;59:e10–e52.
Fox L, Sprunt K. Neonatal osteomyelitis. Pediatrics . 1978;62:535–542.
Knudsen CJ, Hoffman EB. Neonatal osteomyelitis. J Bone Joint Surg Br . 1990;72:846–851.
Markham JL, Hall M, Bettenhausen JL, et al. Variation in care and clinical outcomes in children hospitalized with orbital cellulitis. Hosp Pediatr . 2018;8:21–27.
Biondi EA, Mischler M, Jerardi KE, et al. Blood culture time to positivity in febrile infants with bacteremia. JAMA Pediatr . 2014;168:844–849.
Schnadower D, Kuppermann N, Macias CG, et al. Febrile infants at very low risk for adverse events and bacteremia. Pediatrics . 2010;126:6.
Day CT, Kaplan SL, Mason EO, et al. Community-associated Staphylococcus aureus infections in otherwise healthy infants less than 60 days old. Pediatr Infect Dis J . 2014;33:98–100.
Fortunov RM, Hulten KG, Hammerman WA, et al. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics . 2007;120:937–945.
Hall RT, Domenico HJ, Self WH, et al. Reducing the blood culture contamination rate in a pediatric emergency department and subsequent cost savings. Pediatrics . 2013;131:e292–e297.